Quality of life assessment in renal transplant: Review and future directions

Clinical Transplantation

Volumn 22, Issue 3, 2008, Pages 292-303

  Butt, Zeeshan ^a,b   Yount, Susan E ^a,b   Caicedo, Juan Carlos ^b   Abecassis, Michael M ^b   Cella, David ^a,b  

^a Evanston Northwestern Healthcare   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Assessment; Outcomes; Quality of life; Renal transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

AFFECT BALANCE SCALE; AGE DISTRIBUTION; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CITATION ANALYSIS; CLINICAL TRIAL; DONOR SELECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; END STAGE RENAL DISEASE SYMPTOM CHECKLIST; EUROQOL-5 DIMENSIONS; GRAFT REJECTION; HEALTH STATUS; HUMAN; INDEX OF WELL BEING; KIDNEY DISEASE QUALITY OF LIFE QUESTIONNAIRE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LITERATURE; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL ADJUSTMENT TO ILLNESS SCALE; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE DATABASE; RELIABILITY; RENAL REPLACEMENT THERAPY; REVIEW; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36; SICKNESS IMPACT PROFILE; SYSTEMATIC REVIEW; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION QUALITY OF LIFE QUESTIONNAIRE;

DEPRESSION; HEALTH STATUS INDICATORS; HUMANS; KIDNEY TRANSPLANTATION; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 43749114043     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00784.x     Document Type: Review

References (108)

1. Cella D, Webster K. Linking outcomes management to quality-of-life measurement. Oncology (Williston Park) 1997:11:232.
2. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: The functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 2002:83:S10.
3. World Health Organization. Constitution of the World Health Organization. Geneva: WHO, 1946.
4. Cella DF. Methods and problems in measuring quality of life. Support Care Cancer 1995:3:11.
5. Atherton PJ, Sloan JA. Rising importance of patient-reported outcomes. Lancet Oncol 2006:7:883.
6. Leidy NK, Beusterien K, Sullivan E, Richner R, Muni NI. Integrating the patient's perspective into device evaluation trials. Value Health 2006:9:394.
7. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989:27:S217.
8. Ware JE J r., Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998:7:235.
9. Mc Horney CA, Ware JE Jr., Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994:32:40.
10. Mc Horney CA, Ware JE Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993:31:247.
11. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992:30:473.
12. Rebollo P, Ortega F, Valdes C et.al. Influence of erectile dysfunction on health related quality of life of male kidney transplant patients. Int J Impot Res 2004:16:282.
13. Reimer J, Franke GH, Philipp T, Heemann U. Quality of life in kidney recipients: Comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant 2002:16:48.
14. Shield CF III, Mc Grath MM, Goss TF. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. Transplantation 1997:64:1738.
15. Barotfi S, Molnar MZ, Almasi C et.al. Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosom Res 2006:60:495.
16. Feurer ID, Moore DE, Speroff T et.al. Refining a health-related quality of life assessment strategy for solid organ transplant patients. Clin Transplant 2004:18:39.
17. Isotani S, Fujisawa M, Ichikawa Y et.al. Quality of life of living kidney donors: The short-form 36-item health questionnaire survey. Urology 2002:60:588.
18. Aasebo W, Midtvedt K, Hartmann A, Stavem K. Predictors of health-related quality of life in hypertensive recipients following renal transplantation. Clin Transplant 2005:19:756.
19. Buell JF, Lee L, Martin JE et.al. Laparoscopic donor nephrectomy vs. open live donor nephrectomy: A quality of life and functional study. Clin Transplant 2005:19:102.
20. Neipp M, Karavul B, Jackobs S et.al. Quality of life in adult transplant recipients more than 15years after kidney transplantation. Transplantation 2006:81:1640.
21. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981:19:787.
22. Follick MJ, Smith TW, Ahern DK. The sickness impact profile: A global measure of disability in chronic low back pain. Pain 1985:21:67.
23. Sullivan M, Ahlmen M, Bjelle A, Karlsson J. Health status assessment in rheumatoid arthritis. II. Evaluation of a modified shorter Sickness Impact Profile. J Rheumatol 1993:20:1500.
24. Rothman ML, Hedrick S, Inui T. The Sickness Impact Profile as a measure of the health status of noncognitively impaired nursing home residents. Med Care 1989:27:S157.
25. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998:32:93.
26. Johnson CD, Wicks MN, Milstead J, Hartwig M, Hathaway DK. Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Scholarsh 1998:30:125.
27. Rebollo P, Ortega F, Baltar JM et.al. Health related quality of life (HRQOL) of kidney transplanted patients: Variables that influence it. Clin Transplant 2000:14:199.
28. Cetingok M, Winsett RP, Hathaway DK. A comparative study of quality of life among the age groups of kidney transplant recipients. Prog Transplant 2004:14:33.
29. Cetingo KM, Hathaway DK, Winsett RR. Differences in quality of life before transplantation among transplant recipients with respect to selected socioeconomic variables. Prog Transplant 2005:15:338.
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961:4:561.
31. Gotlib IH, Cane DB. Self-report assessment of depression and anxiety: distinctive and overlapping features. In: K endall PC, W atson D eds. Personality, Psychopathology, and Psychotherapy. San Diego, CA: Academic Press, 1989:131.
32. Clark DA, Steer RA, Beck AT. Common and specific dimensions of self-reported anxiety and depression: Implications for the cognitive and tripartite models. J Abnorm Psychol 1994:103:645.
33. Schlebusch L, Pillay BJ, Louw J. Depression and self-report disclosure after live related donor and cadaver renal transplants. S Afr Med J 1989:75:490.
34. Zimmermann PR, Poli de Figueiredo CE, Fonseca NA. Depression, anxiety and adjustment in renal replacement therapy: A quality of life assessment. Clin Nephrol 2001:56:387.
35. Tanriverdi N, Ozcurumez G, Colak T et.al. Quality of life and mood in renal transplantation recipients, donors, and controls: Preliminary report. Transplant Proc 2004:36:117.
36. Baines LS, Joseph JT, Jindal RM. Emotional issues after kidney transplantation: A prospective psychotherapeutic study. Clin Transplant 2002:16:455.
37. Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int 2004:65:1937.
38. Bradburn N, Caplovitz D. Reports on Happiness: A Pilot Study of Behavior Related to Mental Health. Chicago, IL: Aldine, 1965.
39. Bradburn N. The Structure of Psychological Well-Being. Chicago, IL: Aldine, 1969.
40. Bremer BA, Mc Cauley CR. Quality-of-life measures: Hospital interview versus home questionnaire. Health Psychol 1986:5:171.
41. Binik YM, Devins GM. Transplant failure does not compromise quality of life in end-stage renal disease. Int J Psychiatry Med 1986:16:281.
42. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995:60:914.
43. Hilbrands LB, Hoitsma AJ, Koene RA. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995:59:1263.
44. Simmons RG, Abress L, Anderson CR. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation 1988:45:415.
45. Campbell A, Converse P, Rodgers N. The Quality of American Life: Perceptions, Evaluations, and Satisfactions. New York: Russell Sage Foundation, 1976.
46. Evans RW, Manninen DL, Garrison LP Jr. et.al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985:312:553.
47. Evans RW, Hart LG, Manninen DL. A comparative assessment of the quality of life of successful kidney transplant patients according to source of graft. Transplant Proc 1984:16:1353.
48. Nathan DM, Fogel H, Norman D et.al. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation 1991:52:85.
49. Molzahn AE, Northcott HC, Dossetor JB. Quality of life of individuals with end stage renal disease: Perceptions of patients, nurses, and physicians. ANNA J 1997:24:325.
50. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977:1:385.
51. Devins G, Orme C, Costello C et.al. Measuring depressive symptoms in illness populations: Psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health 1988:2:139.
52. Sheehan T, Fifield J, Reisine S, Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression scale. J Pers Assess 1995:64:507.
53. Devins GM, Mandin H, Hons RB. Illness intrusiveness and quality of life in end-stage renal disease: Comparison and stability across treatment modalities. Health Psychol 1990:9:117.
54. Schimmer AD, Elliott ME, Abbey SE et.al. Illness intrusiveness among survivors of autologous blood and marrow transplantation. Cancer 2001:92:3147.
55. Derogatis L, Derogatis M. The Psychosocial Adjustment to Illness Scale (PAIS and PAIS-SR): Administration, scoring and procedures manual-II. Townson, MD: Clinical Psychometric Research, 1990.
56. Andrykowski MA, Altmaier EM, Barnett RL, Otis ML, Gingrich R, Henslee-Downey PJ. The quality of life in adult survivors of allogeneic bone marrow transplantation. Correlates and comparison with matched renal transplant recipients. Transplantation 1990:50:399.
57. Pinson CW, Feurer ID, Payne JL, Wise PE, Shockley S, Speroff T. Health-related quality of life after different types of solid organ transplantation. Ann Surg 2000:232:597.
58. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998:28:551.
59. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med 1998:46:1569.
60. Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress Anxiety 2007.
61. Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R. Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology 2007:12:240.
62. Yamada K. Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy. Qual Life Res 2007:16:787.
63. Kong IL, Molassiotis A. Quality of life, coping and concerns in Chinese patients after renal transplantation. Int J Nurs Stud 1999:36:313.
64. Tomasz W, Piotr S. A trial of objective comparison of quality of life between chronic renal failure patients treated with hemodialysis and renal transplantation. Ann Transplant 2003:8:47.
65. Niu SF, Li IC. Quality of life of patients having renal replacement therapy. J Adv Nurs 2005:51:15.
66. Lumsdaine JA, Wray A, Power MJ et.al. Higher quality of life in living donor kidney transplantation: Prospective cohort study. Transpl Int 2005:18:975.
67. Rabin R, de CF. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001:33:337.
68. Cleemput I, Kesteloot K, De Geest S, Dobbels F, V anrenterghem Y. Health professionals' perceptions of health status after renal transplantation: A comparison with transplantation candidates' expectations. Transplantation 2003:76:176.
69. Moons P, Vanrenterghem Y, Van Hooff JP et.al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: A multicentre study. Transpl Int 2003:16:653.
70. Lee AJ, Morgan CL, Conway P, Currie CJ. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin 2005:21:1777.
71. Franke GH, Reimer J, Kohnle M, Luetkes P, Maehner N, Heemann U. Quality of life in end-stage renal disease patients after successful kidney transplantation: Development of the ESRD symptom checklist -transplantation module. Nephron 1999:83:31.
72. Franke GH, Yucetin L, Yaman H, Reimer J, Demirbas A. Disease-specific quality of life in Turkish patients after successful kidney transplantation. Transplant Proc 2006:38:457.
73. Stavem K, Ganss R. Reliability and validity of the ESRD Symptom Checklist -Transplantation Module in Norwegian kidney transplant recipients. BMC Nephrol 2006:7:17.
74. Franke GH, Reimer J, Philipp T, Heemann U. Aspects of quality of life through end-stage renal disease. Qual Life Res 2003:12:103.
75. Overbeck I, Bartels M, Decker O, Harms J, Hauss J, Fangmann J. Changes in quality of life after renal transplantation. Transplant Proc 2005:37:1618.
76. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994:3:329.
77. Aaronson NK, Acquadro C, Alonso J et.al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992:1:349.
78. Wagner AK, Gandek B, Aaronson NK et.al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998:51:925.
79. Gomez-Besteiro MI, Santiago-Perez MI, Alonso-Hernandez A, Valdes-Canedo F, Rebollo-Alvarez P. Validity and reliability of the SF-36 questionnaire in patients on the waiting list for a kidney transplant and transplant patients. Am J Nephrol 2004:24:346.
80. Fukuhara S, Lopes AA, Bragg-Gresham JL et.al. Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003:64:1903.
81. Bakewell AB, Higgins RM, Edmunds ME. Does ethnicity influence perceived quality of life of patients on dialysis and following renal transplant? Nephrol Dial Transplant 2001:16:1395.
82. Hicks LS, Cleary PD, Epstein AM, Ayanian JZ. Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res 2004:13:1129.
83. Hasegawa A, Oshima S, Takahashi K, Uchida K, Ito K, Sonoda T. Improvement of quality of life in tacrolimus-based pediatric renal transplant recipients and their caregivers, including donors. Transplant Proc 2005:37:1771.
84. Frimat L, Durand PY, Loos-Ayav C et.al. Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int 2006:26:231.
85. Wu AW, Fink NE, Marsh-M anzi JV et.al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: Generic and disease specific measures. J Am Soc Nephrol 2004:15:743.
86. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 2003:1:79.
87. Lent L, Hahn E, Eremenco S, Webster K, Cella D. Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Acta Oncol 1999:38:695.
88. Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 2005:28:212.
89. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989:10:407.
90. Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: Is there a connection? J Biopharm Stat 2004:14:97.
91. Eton DT, Cella D, Yost KJ et.al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 2004:57:898.
92. Yost KJ, Cella D, Chawla A et.al. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol 2005:58:1241.
93. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Eval Health Prof 2005: 28: 172.
94. Schunemann HJ, Akl EA, Guyatt GH. Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective. Health Qual Life Outcomes 2006:4:62.
95. Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005:2:63.
96. Anastasi A, Urbina S. Psychological Testing, 7th edn. Upper Saddle River, NJ: Prentice Hall, 1997.
97. Lord FM. Application of Item Response Theory to Practical Testing Problems. Hillsdale, NJ: Erlbaum, 1980.
98. Richardson MW. The relationship between difficulty and the differential validity of a test. Psychometrika 1936:1:33.
99. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd edn. Oxford: Oxford University Press, 1995.
100. Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of Item Response Theory. Newbury Park, CA: Sage, 1991.
101. Steinberg L, Thissen D. Item response theory in personality research. In: S hrout P atrick E ed. Personality Research, Methods, and Theory: A Festschrift Honoring Donald W. Fiske. Hillsdale, NJ, US: Lawrence Erlbaum Associates, Inc, 1995:161.
102. Cella D, Chang CH. A discussion of item response theory and its applications in health status assessment. Med Care 2000:38:II66.
103. Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st century. Med Care 2000:38:II28.
104. Embretson SE, Reise SP. Item Response Theory for Psychologists. Mahwah, NJ: Erlbaum, 2000.
105. Embretson SE. The continued search for nonarbitrary metrics in psychology. Am Psychol 2006:61:50.
106. Weiss DJ. Computerized adaptive testing for effective and efficient measurement in counseling and education. Meas Eval Couns Dev 2004:37:70.
107. Reise SP, Haviland MG. Item response theory and the measurement of clinical change. J Pers Assess 2005:84:228.
108. Reise SP, Ainsworth AT, Haviland MG. Item response theory: Fundamentals, applications, and promise in psychological research. Curr Dir Psychol Sci 2005:14:95.